99 related articles for article (PubMed ID: 21429301)
21. Lack of correlation between p53 protein level and sensitivity of DNA-damaging agents in keratinocytes carrying adenovirus E1a mutants.
Sanchez-Prieto R; Lleonart M; Ramón y Cajal S
Oncogene; 1995 Aug; 11(4):675-82. PubMed ID: 7651731
[TBL] [Abstract][Full Text] [Related]
22. Formation of nuclear Bax/p53 complexes is associated with chemotherapy induced apoptosis.
Raffo AJ; Kim AL; Fine RL
Oncogene; 2000 Dec; 19(54):6216-28. PubMed ID: 11175336
[TBL] [Abstract][Full Text] [Related]
23. Increased sensitivity of a metastatic model of prostate cancer to a novel tetravalent platinum analog.
Mujoo K; Watanabe M; Khokhar AR; Siddik ZH
Prostate; 2005 Jan; 62(1):91-100. PubMed ID: 15389812
[TBL] [Abstract][Full Text] [Related]
24. Akt-mediated cisplatin resistance in ovarian cancer: modulation of p53 action on caspase-dependent mitochondrial death pathway.
Yang X; Fraser M; Moll UM; Basak A; Tsang BK
Cancer Res; 2006 Mar; 66(6):3126-36. PubMed ID: 16540663
[TBL] [Abstract][Full Text] [Related]
25. Sensitizing effect of galectin-7 in urothelial cancer to cisplatin through the accumulation of intracellular reactive oxygen species.
Matsui Y; Ueda S; Watanabe J; Kuwabara I; Ogawa O; Nishiyama H
Cancer Res; 2007 Feb; 67(3):1212-20. PubMed ID: 17283157
[TBL] [Abstract][Full Text] [Related]
26. Human bladder cancer cells undergo cisplatin-induced apoptosis that is associated with p53-dependent and p53-independent responses.
Konstantakou EG; Voutsinas GE; Karkoulis PK; Aravantinos G; Margaritis LH; Stravopodis DJ
Int J Oncol; 2009 Aug; 35(2):401-16. PubMed ID: 19578756
[TBL] [Abstract][Full Text] [Related]
27. Potential role of transforming growth factor beta1 in drug resistance of tumor cells.
Stoika R; Yakymovych M; Souchelnytskyi S; Yakymovych I
Acta Biochim Pol; 2003; 50(2):497-508. PubMed ID: 12833174
[TBL] [Abstract][Full Text] [Related]
28. Apoptosis-inducing activity of cisplatin (CDDP) against human hepatoma and oral squamous cell carcinoma cell lines.
Okamura M; Hashimoto K; Shimada J; Sakagami H
Anticancer Res; 2004; 24(2B):655-61. PubMed ID: 15161008
[TBL] [Abstract][Full Text] [Related]
29. Role of intracellular glutathione in cell sensitivity to the apoptosis induced by tumor necrosis factor {alpha}-related apoptosis-inducing ligand/anticancer drug combinations.
Meurette O; Lefeuvre-Orfila L; Rebillard A; Lagadic-Gossmann D; Dimanche-Boitrel MT
Clin Cancer Res; 2005 Apr; 11(8):3075-83. PubMed ID: 15837763
[TBL] [Abstract][Full Text] [Related]
30. Increasing p53 protein sensitizes non-small cell lung cancer to paclitaxel and cisplatin in vitro.
Guntur VP; Waldrep JC; Guo JJ; Selting K; Dhand R
Anticancer Res; 2010 Sep; 30(9):3557-64. PubMed ID: 20944137
[TBL] [Abstract][Full Text] [Related]
31. Dicoumarol potentiates cisplatin-induced apoptosis mediated by c-Jun N-terminal kinase in p53 wild-type urogenital cancer cell lines.
Watanabe J; Nishiyama H; Matsui Y; Ito M; Kawanishi H; Kamoto T; Ogawa O
Oncogene; 2006 Apr; 25(17):2500-8. PubMed ID: 16518417
[TBL] [Abstract][Full Text] [Related]
32. Apoptosis induced by 5-fluorouracil, cisplatin and paclitaxel are associated with p53 gene status in gastric cancer cell lines.
Matsuhashi N; Saio M; Matsuo A; Sugiyama Y; Saji S
Int J Oncol; 2005 Jun; 26(6):1563-7. PubMed ID: 15870870
[TBL] [Abstract][Full Text] [Related]
33. Cellular components involved in the cell death induced by cisplatin in the absence of p53 activation.
Bae IH; Kang SW; Yoon SH; Um HD
Oncol Rep; 2006 May; 15(5):1175-80. PubMed ID: 16596182
[TBL] [Abstract][Full Text] [Related]
34. Synergistic effect of combining paeonol and cisplatin on apoptotic induction of human hepatoma cell lines.
Xu SP; Sun GP; Shen YX; Peng WR; Wang H; Wei W
Acta Pharmacol Sin; 2007 Jun; 28(6):869-78. PubMed ID: 17506946
[TBL] [Abstract][Full Text] [Related]
35. Mutant p53 protein expression interferes with p53-independent apoptotic pathways.
Li R; Sutphin PD; Schwartz D; Matas D; Almog N; Wolkowicz R; Goldfinger N; Pei H; Prokocimer M; Rotter V
Oncogene; 1998 Jun; 16(25):3269-77. PubMed ID: 9681825
[TBL] [Abstract][Full Text] [Related]
36. Analysis of cellular sensitization with cisplatin-induced apoptosis by glucose-starved stress in cisplatin-sensitive and -resistant A431 cell line.
Mese H; Sasaki A; Nakayama S; Yokoyama S; Sawada S; Ishikawa T; Matsumura T
Anticancer Res; 2001; 21(2A):1029-33. PubMed ID: 11396136
[TBL] [Abstract][Full Text] [Related]
37. [Relation between p53 expression of human colon cancer cell lines and induction of apoptosis by anticancer drugs].
Matsuhashi N; Matsuo A; Kawaguchi Y; Sugiyama Y; Saji S
Gan To Kagaku Ryoho; 2003 Oct; 30(11):1855-8. PubMed ID: 14619538
[TBL] [Abstract][Full Text] [Related]
38. Regulation of apoptosis reduction in the cisplatin-resistant A431 cell line by Bcl-2 and CPP32.
Mese H; Sasaki A; Alcalde RE; Nakayama S; Matsumura T
Chemotherapy; 2000; 46(1):69-76. PubMed ID: 10601800
[TBL] [Abstract][Full Text] [Related]
39. p53 is required for cisplatin-induced processing of the mitochondrial fusion protein L-Opa1 that is mediated by the mitochondrial metallopeptidase Oma1 in gynecologic cancers.
Kong B; Wang Q; Fung E; Xue K; Tsang BK
J Biol Chem; 2014 Sep; 289(39):27134-27145. PubMed ID: 25112877
[TBL] [Abstract][Full Text] [Related]
40. Cisplatin disrupts the latency of human herpesvirus 8 and induces apoptosis in primary effusion lymphoma cells.
Wang YF; Chiou YH; Wang LY; Chang ST; Shyu HW; Chen CY; Lin KH; Chou MC
Cancer Invest; 2012 May; 30(4):268-74. PubMed ID: 22480174
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]